Park Avenue Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Park Avenue Securities’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$225K	Buy
2025 Q2	–	Sell
2025 Q1	$178K	Sell
2024 Q4	$274K	Buy
2024 Q3	$182K	Sell
2024 Q2	$189K	Sell
2024 Q1	$248K	Buy
2022 Q4	–	Sell
2022 Q3	$96K	Buy